Presentation TCT 2021 BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease Presenter: Eline Ploumen November 06, 2021
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
Presentation TCT 2021 The Role of Drug Coated Balloons in Bifurcation Lesions Presenter: Robert Byrne November 04, 2021
News Conference News TCT 2021 ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients Yael L. Maxwell November 04, 2021
News Conference News TCT 2021 FAVOR III China Adds Strength to Value of QFR-Guided PCI L.A. McKeown November 04, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
Presentation TCT 2021 FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes Presenter: Matthias Lutz November 04, 2021
Presentation TCT 2021 TCT 719: Title: OCT guided management of old ISR and old unattended dissected vessel with Calcified Neoatherosclerosis using Cutting balloons and OPN followed by DES implantation Presenter: Inderjeet Monga November 04, 2021
Presentation TCT 2021 Recognizing the Value Proposition of DCB in the Real-World Presenter: David Cohen November 04, 2021
Presentation TCT 2021 Where are we now? Current Global Acceptance of Coronary DCB as a Standard of Care vs. DES Presenter: Bruno Scheller November 04, 2021
News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News TCT 2021 Good Long-term Results With FANTOM BVS, but More Data Needed Michael O'Riordan October 21, 2021
News Conference News TCT 2021 No Harm From Thrombolytics in SCAD Patients With STEMI Michael O'Riordan October 13, 2021